Severe hemorrhagic complication due to acquired factor V inhibitor after single exposure to bovine thrombin product.
about
Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety.Clinical use of topical thrombin as a surgical hemostat.Thrombin use in surgery: an evidence-based review of its clinical use.Whole blood thrombin: development of a process for intra-operative production of human thrombin.Stability of human thrombin produced from 11 ml of plasma using the thrombin processing device
P2860
Severe hemorrhagic complication due to acquired factor V inhibitor after single exposure to bovine thrombin product.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Severe hemorrhagic complicatio ...... re to bovine thrombin product.
@ast
Severe hemorrhagic complicatio ...... re to bovine thrombin product.
@en
Severe hemorrhagic complicatio ...... re to bovine thrombin product.
@nl
type
label
Severe hemorrhagic complicatio ...... re to bovine thrombin product.
@ast
Severe hemorrhagic complicatio ...... re to bovine thrombin product.
@en
Severe hemorrhagic complicatio ...... re to bovine thrombin product.
@nl
prefLabel
Severe hemorrhagic complicatio ...... re to bovine thrombin product.
@ast
Severe hemorrhagic complicatio ...... re to bovine thrombin product.
@en
Severe hemorrhagic complicatio ...... re to bovine thrombin product.
@nl
P2093
P1476
Severe hemorrhagic complicatio ...... ure to bovine thrombin product
@en
P2093
P304
P356
10.1111/J.1540-8191.2000.TB01296.X
P577
2000-11-01T00:00:00Z